Viability studies To assess drug response, 20 10 4 MV4;11 or HL-60 cells were seeded per well in a non-tissue-culture-treated 96-well plate (VWR) and treated with 0.1% DMSO or increasing concentrations of ( R )-dHTC1 or ( S )-dHTC1 (39.07 nM, 78.13 nM, 156 nM, 312 nM, 625 nM, 1.25 M, 2.5 M, 5 M and 10 M)
Key Benefits: Cardiovascular Support: Increases the energy and oxygenation of cardiac muscle cells Male Fertility Support: Improves sperm count, motility, and morphology Nutritional Replenishment: Provides essential vitamins and minerals for reproductive health Improved Bioavailability: Liposomal technology guarantees improved absorption
Milk Chocolate is my favorite flavor, though options like Chocolate Peanut Butter, S'Mores and Mocha are available as well
Semaglutide and B12 Improve Nutrient Absorption B12 enhances Semaglutide by supporting digestive health

Pre-Blend Reconstitution Math (12.5/2.5 mg, 15 mg total) Metric Blend composition Value 12.5 mg retatrutide + 2.5 mg cagrilintide Metric BAC water added Value 2.5 mL Metric Concentration Value 5.0 mg/mL retatrutide + 1.0 mg/mL cagrilintide Metric Ratio held constant Value 5:1 (reta : cag) What Each Draw Delivers (12.5/2.5 mg Pre-Blend) Draw Volume 0.20 mL Units 20 units Retatrutide 1.0 mg Cagrilintide 0.2 mg Draw Volume 0.40 mL Units 40 units Retatrutide 2.0 mg Cagrilintide 0.4 mg Draw Volume 0.60 mL Units 60 units Retatrutide 3.0 mg Cagrilintide 0.6 mg Draw Volume 0.80 mL Units 80 units Retatrutide 4.0 mg Cagrilintide 0.8 mg Draw Volume 1.20 mL Units 120 units* Retatrutide 6.0 mg Cagrilintide 1.2 mg Draw Volume 1.60 mL Units 160 units* Retatrutide 8.0 mg Cagrilintide 1.6 mg Draw Volume 2.40 mL Units 240 units* Retatrutide 12.0 mg Cagrilintide 2.4 mg * Volumes above 100 units exceed a standard 1 mL insulin syringe - split into two injections or use a larger syringe

Epithalon induces decondensation of heterochromatin, particularly pericentromeric structural heterochromatin, releasing genes that become repressed due to age-related chromatin condensation